https://optionstrading.zone/market-insights/marriott-q2-2026-earnings-on-august-3-what-lodging-demand-and-revpar-may-change-for-mar-options/ OptionsTrading.Zone en 2026-08-02T10:29:57Z Marriott Q2 2026 earnings on August 3: what RevPAR and travel demand may change for MAR options https://optionstrading.zone/market-insights/palantir-q2-2026-earnings-on-august-3-what-this-ai-software-setup-may-change-for-pltr-options/ OptionsTrading.Zone en 2026-08-02T08:28:10Z Palantir Q2 2026 earnings on August 3: what a high growth bar may change for PLTR options https://optionstrading.zone/market-insights/skywater-merger-closes-and-occ-memo-59492-turns-skyt-options-into-ionq1-with-delayed-settlement/ OptionsTrading.Zone en 2026-08-01T18:24:36Z OCC memo 59492 moves SKYT options to IONQ1 with delayed settlement https://optionstrading.zone/market-insights/exxonmobil-q2-2026-results-what-usd-14-5-billion-of-earnings-usd-17-2-billion-of-free-cash-flow-/ OptionsTrading.Zone en 2026-08-01T10:18:16Z ExxonMobil Q2 2026 results: what record cash flow, buybacks, and Permian output mean for XOM options https://optionstrading.zone/market-insights/moderna-q2-2026-results-what-a-weaker-revenue-quarter-tighter-cash-outlook-and-the-norovirus-pha/ OptionsTrading.Zone en 2026-08-01T08:18:15Z Moderna Q2 2026 results: what weak revenue, better cash guidance, and the norovirus setback mean for MRNA options https://optionstrading.zone/market-insights/abbvie-q2-2026-results-what-stronger-immunology-growth-and-a-clean-july-31-earnings-beat-change-/ OptionsTrading.Zone en 2026-08-01T06:23:11Z AbbVie Q2 2026 results: what Skyrizi, Rinvoq, and lower 2026 EPS guidance mean for ABBV options